Skip to content

Associations between adolescent cannabis use and neuropsychological decline: a longitudinal co‐twin control study

Madeline H. Meier, Avshalom Caspi, Andrea Danese, Helen Louise Fisher, Renate Houts, Louise Arseneault, Terrie E. Moffitt

Addiction July 22, 2017 DOI: 10.1111/add.13946 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Longitudinal co-twin control study Peer reviewed
Sample size 1,989
Population 1989 twins from the Environmental Risk (E-Risk) Longitudinal Twin Study, a nationally representative birth cohort of twins born in England and Wales in 1994-1995
Measures IQ, Spatial Span reversed
Topics Cannabis
Citations 129
Key findings Adolescents who used cannabis or met criteria for dependence had lower IQ both before cannabis initiation and at age 18 (e.g., 5.61 and 7.34 IQ points lower at ages 12 and 18 for those with dependence), but showed little evidence of greater IQ decline from ages 12 to 18. Executive function differences at age 18 were generally not apparent within twin pairs, with one exception on a working memory test. The authors conclude that short-term adolescent cannabis use does not appear to cause IQ decline or impair executive functions, and that family background factors explain the observed differences.

Abstract

Aims: This study tested whether adolescents who used cannabis or met criteria for cannabis dependence showed neuropsychological impairment prior to cannabis initiation and neuropsychological decline from before to after cannabis initiation.

Design: A longitudinal co-twin control study.

Setting: AND

Participants: Participants were 1989 twins from the Environmental Risk (E-Risk) Longitudinal Twin Study, a nationally representative birth cohort of twins born in England and Wales from 1994 to 1995.

Measurements: Frequency of cannabis use and cannabis dependence were assessed at age 18. Intelligence quotient (IQ) was obtained at ages 5, 12 and 18. Executive functions were assessed at age 18.

Findings: Compared with adolescents who did not use cannabis, adolescents who used cannabis had lower IQ in childhood prior to cannabis initiation and lower IQ at age 18, but there was little evidence that cannabis use was associated with IQ decline from ages 12-18. For example, adolescents with cannabis dependence had age 12 and age 18 IQ scores that were 5.61 (t = -3.11, P = 0.002) and 7.34 IQ points (t = -5.27, P < 0.001) lower than adolescents without cannabis dependence, but adolescents with cannabis dependence did not show greater IQ decline from age 12-18 (t = -1.27, P = 0.20). Moreover, adolescents who used cannabis had poorer executive functions at age 18 than adolescents who did not use cannabis, but these associations were generally not apparent within twin pairs. For example, twins who used cannabis more frequently than their co-twin performed similarly to their co-twin on five of six executive function tests (Ps > 0.10). The one exception was that twins who used cannabis more frequently than their co-twin performed worse on one working memory test (Spatial Span reversed; β = -0.07, P = 0.036).

Conclusions: Short-term cannabis use in adolescence does not appear to cause IQ decline or impair executive functions, even when cannabis use reaches the level of dependence. Family background factors explain why adolescent cannabis users perform worse on IQ and executive function tests.

Comparable studies

Other observational and cohort studies on cannabis, most cited first.

Study Year Design Participants
High-potency cannabis and the risk of psychosis People with first episode of psychosis and healthy controls from the local population 2009 Case-control study n = 454
Ayahuasca-Assisted Therapy for Addiction: Results from a Preliminary Observational Study in Canada Rural aboriginal population 2013 Observational study
Impaired cognitive performance in drug free users of recreational ecstasy (MDMA) Otherwise healthy young people 2000 Observational
Continued cannabis use and risk of incidence and persistence of psychotic symptoms: 10 year follow-up cohort study Individuals from the general population in Germany aged 14-24 at baseline 2011 Observational cohort n = 1,923
Cannabis-induced psychosis and subsequent schizophrenia-spectrum disorders: follow-up study of 535 incident cases Patients treated for cannabis-induced psychotic symptoms in Denmark between 1994 and... 2005 Observational cohort n = 535

Citations in the library

Explore topics